US Tissue Diagnostics Market Size, Share, Analysis, Trends, Growth, Forecasts, 2032
US Tissue Diagnostics Market By Technology (Immunohistochemistry, In situ Hybridization, Primary & Special Staining, Digital Pathology & Workflow, and Anatomic Pathology), By Application (Breast Cancer, Non-Small Cell Lung Cancer (NSCLC), Prostate Cancer, Gastric Cancer, and Other Cancers), and By Country-State Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2024 - 2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 2,156 Million | USD 3,897 Million | 6.8% | 2023 |
Table Of Content
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global US Tissue Diagnostics Market, (2024 - 2032) (USD Million)
- 2.2 Global US Tissue Diagnostics Market : snapshot
- Chapter 3. Global US Tissue Diagnostics Market - Industry Analysis
- 3.1 US Tissue Diagnostics Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Advancements in technology drive market growth
- 3.3 Market Restraints
- 3.3.1. High-cost related R&D and clinical trials impede market growth
- 3.4 Market Opportunities
- 3.4.1. Growing collaboration among the key market players provides a lucrative opportunity for market growth
- 3.5 Market Challenges
- 3.5.1. A stringent approval process poses a major challenge to market expansion
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Technology
- 3.7.2 Market attractiveness analysis By Application
- Chapter 4. Global US Tissue Diagnostics Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global US Tissue Diagnostics Market: company market share, 2023
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global US Tissue Diagnostics Market - Technology Analysis
- 5.1 Global US Tissue Diagnostics Market overview: By Technology
- 5.1.1 Global US Tissue Diagnostics Market share, By Technology, 2023 and 2032
- 5.2 Immunohistochemistry
- 5.2.1 Global US Tissue Diagnostics Market by Immunohistochemistry, 2024 - 2032 (USD Million)
- 5.3 In situ Hybridization
- 5.3.1 Global US Tissue Diagnostics Market by In situ Hybridization, 2024 - 2032 (USD Million)
- 5.4 Primary & Special Staining
- 5.4.1 Global US Tissue Diagnostics Market by Primary & Special Staining, 2024 - 2032 (USD Million)
- 5.5 Digital Pathology & Workflow
- 5.5.1 Global US Tissue Diagnostics Market by Digital Pathology & Workflow, 2024 - 2032 (USD Million)
- 5.6 Anatomic Pathology
- 5.6.1 Global US Tissue Diagnostics Market by Anatomic Pathology, 2024 - 2032 (USD Million)
- 5.1 Global US Tissue Diagnostics Market overview: By Technology
- Chapter 6. Global US Tissue Diagnostics Market - Application Analysis
- 6.1 Global US Tissue Diagnostics Market overview: By Application
- 6.1.1 Global US Tissue Diagnostics Market share, By Application, 2023 and 2032
- 6.2 Breast Cancer
- 6.2.1 Global US Tissue Diagnostics Market by Breast Cancer, 2024 - 2032 (USD Million)
- 6.3 Non-Small Cell Lung Cancer (NSCLC)
- 6.3.1 Global US Tissue Diagnostics Market by Non-Small Cell Lung Cancer (NSCLC), 2024 - 2032 (USD Million)
- 6.4 Prostate Cancer
- 6.4.1 Global US Tissue Diagnostics Market by Prostate Cancer, 2024 - 2032 (USD Million)
- 6.5 Gastric Cancer
- 6.5.1 Global US Tissue Diagnostics Market by Gastric Cancer, 2024 - 2032 (USD Million)
- 6.6 Other Cancers
- 6.6.1 Global US Tissue Diagnostics Market by Other Cancers, 2024 - 2032 (USD Million)
- 6.1 Global US Tissue Diagnostics Market overview: By Application
- Chapter 7. US Tissue Diagnostics Market - Regional Analysis
- 7.1 Global US Tissue Diagnostics Market Regional Overview
- 7.2 Global US Tissue Diagnostics Market Share, by Region, 2023 & 2032 (USD Million)
- 7.3. U.S.
- 7.3.1 U.S. US Tissue Diagnostics Market, 2024 - 2032 (USD Million)
- 7.3.1.1 U.S. US Tissue Diagnostics Market, by Country, 2024 - 2032 (USD Million)
- 7.3.1 U.S. US Tissue Diagnostics Market, 2024 - 2032 (USD Million)
- 7.4 U.S. US Tissue Diagnostics Market, by Technology, 2024 - 2032
- 7.4.1 U.S. US Tissue Diagnostics Market, by Technology, 2024 - 2032 (USD Million)
- 7.5 U.S. US Tissue Diagnostics Market, by Application, 2024 - 2032
- 7.5.1 U.S. US Tissue Diagnostics Market, by Application, 2024 - 2032 (USD Million)
- Chapter 8. Company Profiles
- 8.1 Thermo Fisher Scientific Inc.
- 8.1.1 Overview
- 8.1.2 Financials
- 8.1.3 Product Portfolio
- 8.1.4 Business Strategy
- 8.1.5 Recent Developments
- 8.2 Merck KGaA
- 8.2.1 Overview
- 8.2.2 Financials
- 8.2.3 Product Portfolio
- 8.2.4 Business Strategy
- 8.2.5 Recent Developments
- 8.3 F. Hoffmann-La Roche Ltd.
- 8.3.1 Overview
- 8.3.2 Financials
- 8.3.3 Product Portfolio
- 8.3.4 Business Strategy
- 8.3.5 Recent Developments
- 8.4 Siemens Healthineers AG
- 8.4.1 Overview
- 8.4.2 Financials
- 8.4.3 Product Portfolio
- 8.4.4 Business Strategy
- 8.4.5 Recent Developments
- 8.5 Abbott Laboratories
- 8.5.1 Overview
- 8.5.2 Financials
- 8.5.3 Product Portfolio
- 8.5.4 Business Strategy
- 8.5.5 Recent Developments
- 8.6 Danaher
- 8.6.1 Overview
- 8.6.2 Financials
- 8.6.3 Product Portfolio
- 8.6.4 Business Strategy
- 8.6.5 Recent Developments
- 8.7 QIAGEN
- 8.7.1 Overview
- 8.7.2 Financials
- 8.7.3 Product Portfolio
- 8.7.4 Business Strategy
- 8.7.5 Recent Developments
- 8.8 bioMérieux SA
- 8.8.1 Overview
- 8.8.2 Financials
- 8.8.3 Product Portfolio
- 8.8.4 Business Strategy
- 8.8.5 Recent Developments
- 8.9 Becton
- 8.9.1 Overview
- 8.9.2 Financials
- 8.9.3 Product Portfolio
- 8.9.4 Business Strategy
- 8.9.5 Recent Developments
- 8.10 Dickinson & Company (BD
- 8.10.1 Overview
- 8.10.2 Financials
- 8.10.3 Product Portfolio
- 8.10.4 Business Strategy
- 8.10.5 Recent Developments
- 8.11 Agilent Technologies Inc.
- 8.11.1 Overview
- 8.11.2 Financials
- 8.11.3 Product Portfolio
- 8.11.4 Business Strategy
- 8.11.5 Recent Developments
- 8.12 DiaGenic ASA
- 8.12.1 Overview
- 8.12.2 Financials
- 8.12.3 Product Portfolio
- 8.12.4 Business Strategy
- 8.12.5 Recent Developments
- 8.13 General Electric Company (GE Healthcare)
- 8.13.1 Overview
- 8.13.2 Financials
- 8.13.3 Product Portfolio
- 8.13.4 Business Strategy
- 8.13.5 Recent Developments
- 8.14 BioGenex
- 8.14.1 Overview
- 8.14.2 Financials
- 8.14.3 Product Portfolio
- 8.14.4 Business Strategy
- 8.14.5 Recent Developments
- 8.15 Cell Signaling Technology Inc.
- 8.15.1 Overview
- 8.15.2 Financials
- 8.15.3 Product Portfolio
- 8.15.4 Business Strategy
- 8.15.5 Recent Developments
- 8.16 Abcam plc
- 8.16.1 Overview
- 8.16.2 Financials
- 8.16.3 Product Portfolio
- 8.16.4 Business Strategy
- 8.16.5 Recent Developments
- 8.17 Bio SB
- 8.17.1 Overview
- 8.17.2 Financials
- 8.17.3 Product Portfolio
- 8.17.4 Business Strategy
- 8.17.5 Recent Developments
- 8.18 Enzo Life Sciences Inc.
- 8.18.1 Overview
- 8.18.2 Financials
- 8.18.3 Product Portfolio
- 8.18.4 Business Strategy
- 8.18.5 Recent Developments
- 8.19 VITRO SA (Master Diagnóstica)
- 8.19.1 Overview
- 8.19.2 Financials
- 8.19.3 Product Portfolio
- 8.19.4 Business Strategy
- 8.19.5 Recent Developments
- 8.20 TissueGnostics GmbH
- 8.20.1 Overview
- 8.20.2 Financials
- 8.20.3 Product Portfolio
- 8.20.4 Business Strategy
- 8.20.5 Recent Developments
- 8.21 and others.
- 8.21.1 Overview
- 8.21.2 Financials
- 8.21.3 Product Portfolio
- 8.21.4 Business Strategy
- 8.21.5 Recent Developments
- 8.1 Thermo Fisher Scientific Inc.
Table Of Figures
- 1. Market research Type
- 2. Market research methodology
- 3. Global US Tissue Diagnostics Market, 2024 - 2032 (USD Million)
- 4. Porter’s Five Forces Analysis
- 5. Global US Tissue Diagnostics Market attractiveness, By Technology
- 6. Global US Tissue Diagnostics Market attractiveness, By Application
- 7. Global US Tissue Diagnostics Market share by Technology, 2024 and 2032 (USD Million)
- 8. Global US Tissue Diagnostics Market by Immunohistochemistry, 2024 - 2032 (USD Million)
- 9. Global US Tissue Diagnostics Market by In situ Hybridization, 2024 - 2032 (USD Million)
- 10. Global US Tissue Diagnostics Market by Primary & Special Staining, 2024 - 2032 (USD Million)
- 11. Global US Tissue Diagnostics Market by Digital Pathology & Workflow, 2024 - 2032 (USD Million)
- 12. Global US Tissue Diagnostics Market by Anatomic Pathology, 2024 - 2032 (USD Million)
- 13. Global US Tissue Diagnostics Market share by Application, 2024 and 2032 (USD Million)
- 14. Global US Tissue Diagnostics Market by Breast Cancer, 2024 - 2032 (USD Million)
- 15. Global US Tissue Diagnostics Market by Non-Small Cell Lung Cancer (NSCLC), 2024 - 2032 (USD Million)
- 16. Global US Tissue Diagnostics Market by Prostate Cancer, 2024 - 2032 (USD Million)
- 17. Global US Tissue Diagnostics Market by Gastric Cancer, 2024 - 2032 (USD Million)
- 18. Global US Tissue Diagnostics Market by Other Cancers, 2024 - 2032 (USD Million)
- 19. Global US Tissue Diagnostics Market share, by Region, 2024 and 2032
- 20. U.S. US Tissue Diagnostics Market, 2024 - 2032 (USD Million)
Table Of Tables
- 1. Global US Tissue Diagnostics Market: Snapshot
- 2. Drivers of the US Tissue Diagnostics Market: impact analysis
- 3. U.S. US Tissue Diagnostics Market revenue, By Technology, 2024 - 2032 (USD Million)
- 4. U.S. US Tissue Diagnostics Market revenue, By Application, 2024 - 2032 (USD Million)
- 5. California US Tissue Diagnostics Market revenue, By Technology, 2024 - 2032 (USD Million)
- 6. California US Tissue Diagnostics Market revenue, By Application, 2024 - 2032 (USD Million)
- 7. Florida US Tissue Diagnostics Market revenue, By Technology, 2024 - 2032 (USD Million)
- 8. Florida US Tissue Diagnostics Market revenue, By Application, 2024 - 2032 (USD Million)
- 9. New York US Tissue Diagnostics Market revenue, By Technology, 2024 - 2032 (USD Million)
- 10. New York US Tissue Diagnostics Market revenue, By Application, 2024 - 2032 (USD Million)
- 11. Washington US Tissue Diagnostics Market revenue, By Technology, 2024 - 2032 (USD Million)
- 12. Washington US Tissue Diagnostics Market revenue, By Application, 2024 - 2032 (USD Million)
- 13. Texas US Tissue Diagnostics Market revenue, By Technology, 2024 - 2032 (USD Million)
- 14. Texas US Tissue Diagnostics Market revenue, By Application, 2024 - 2032 (USD Million)
- 15. New Jersey US Tissue Diagnostics Market revenue, By Technology, 2024 - 2032 (USD Million)
- 16. New Jersey US Tissue Diagnostics Market revenue, By Application, 2024 - 2032 (USD Million)
- 17. Georgia US Tissue Diagnostics Market revenue, By Technology, 2024 - 2032 (USD Million)
- 18. Georgia US Tissue Diagnostics Market revenue, By Application, 2024 - 2032 (USD Million)
- 19. Oregon US Tissue Diagnostics Market revenue, By Technology, 2024 - 2032 (USD Million)
- 20. Oregon US Tissue Diagnostics Market revenue, By Application, 2024 - 2032 (USD Million)
- 21. Arizona US Tissue Diagnostics Market revenue, By Technology, 2024 - 2032 (USD Million)
- 22. Arizona US Tissue Diagnostics Market revenue, By Application, 2024 - 2032 (USD Million)
- 23. Colorado US Tissue Diagnostics Market revenue, By Technology, 2024 - 2032 (USD Million)
- 24. Colorado US Tissue Diagnostics Market revenue, By Application, 2024 - 2032 (USD Million)
Methodology
FrequentlyAsked Questions
By determining the biological background of diseases, tissue diagnostics involves the examination and testing of particular tissue samples. They help uncover possible causes and treatment choices by revealing the precise type and degree of malignancy, which is utilized to detect specific medical illnesses like cancer and inflammatory disorders. Tissue diagnostics can be performed using a variety of methods, including core and open biopsy, and are very accurate and reasonably priced. These days, these diagnoses are also made using sophisticated technologies including digital pathology, in situ hybridization (ISH), immunohistochemistry (IHC), and special staining.
The US tissue diagnostics market is being driven by several factors such as the growing prevalence of cancer, technological advancements, increasing elderly population, rising government initiatives, growing collaboration among the key market players, and others.
According to the report, the US tissue diagnostics market size was worth around USD 2,156 million in 2023 and is predicted to grow to around USD 3,897 million by 2032.
The US tissue diagnostics market is expected to grow at a CAGR of 6.8% during the forecast period.
US tissue diagnostics market growth is driven by California. It is currently the nation's highest revenue-generating market due to the prevalence of cancer.
The US tissue diagnostics market is dominated by players like Thermo Fisher Scientific, Inc., Merck KGaA, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Abbott Laboratories, Danaher, QIAGEN, bioMérieux SA, Becton, Dickinson & Company (BD, Agilent Technologies, Inc., DiaGenic ASA, General Electric Company (GE Healthcare), BioGenex, Cell Signaling Technology, Inc., Abcam plc, Bio SB, Enzo Life Sciences, Inc., VITRO SA (Master Diagnóstica) and TissueGnostics GmbH among others.
The US tissue diagnostics market report covers the geographical market along with a comprehensive Tissue Diagnostics competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, sentiment analysis, PESTLE analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five forces analysis, and value chain analysis.
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed